Clinical Trial Update: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in Japanese patients with acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-11